Holen Sie sich die Stockscreener-App
1.00
8.70%
0.08
Handel nachbörslich:
1.00
Schlusskurs vom Vortag:
$0.92
Offen:
$0.93
24-Stunden-Volumen:
802.10K
Relative Volume:
1.68
Marktkapitalisierung:
$67.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-46.12M
KGV:
-1.1571
EPS:
-0.8642
Netto-Cashflow:
$-41.02M
1W Leistung:
+11.99%
1M Leistung:
+11.27%
6M Leistung:
-25.93%
1J Leistung:
-38.65%
1-Tages-Spanne:
$0.914
$1.02
1-Wochen-Bereich:
$0.82
$1.02
52-Wochen-Spanne:
$0.7113
$2.815
Inflarx N V Stock (IFRX) Company Profile
Vergleichen Sie IFRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IFRX
Inflarx N V
|
1.00 | 62.33M | 0 | -46.12M | -41.02M | -0.8642 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Inflarx N V Stock (IFRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-29 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-05 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-02-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-10-28 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-03-11 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-11-06 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-10-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-06-17 | Eingeleitet | BTIG Research | Buy |
| 2020-04-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-06-05 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-06-05 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-06-05 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2019-06-05 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-06-05 | Herabstufung | SunTrust | Buy → Hold |
| 2019-01-29 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-12-10 | Eingeleitet | Credit Suisse | Outperform |
| 2018-07-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2018-06-28 | Eingeleitet | Raymond James | Outperform |
| 2018-06-28 | Eingeleitet | SunTrust | Buy |
| 2018-02-08 | Eingeleitet | B. Riley FBR, Inc. | Buy |
Alle ansehen
Inflarx N V Aktie (IFRX) Neueste Nachrichten
Leading vs lagging indicators on InflaRx N.V. performance2025 Trading Recap & Low Risk High Win Rate Picks - Newser
What momentum shifts mean for InflaRx N.V.2025 Key Highlights & AI Forecast for Swing Trade Picks - Newser
How high can InflaRx N.V. stock go2025 Year in Review & Weekly Top Gainers Alerts - Newser
Top chart patterns to watch in InflaRx N.V.Weekly Trading Summary & Pattern Based Trade Signal System - Newser
Is InflaRx N.V. stock reversal real or fakePortfolio Risk Summary & Growth Focused Entry Point Reports - Newser
Tools to assess InflaRx N.V.’s risk profileEarnings Growth Summary & Expert Curated Trade Setup Alerts - Newser
Detecting support and resistance levels for InflaRx N.V.Entry Point & High Conviction Trade Alerts - Newser
Is InflaRx N.V. forming a bottoming baseIPO Watch & Real-Time Chart Pattern Alerts - Newser
Can swing trading help recover from InflaRx N.V. lossesTreasury Yields & Daily Profit Focused Screening - Newser
Predicting InflaRx N.V. trend using moving averagesPrice Action & Risk Controlled Daily Trade Plans - Newser
InflaRx N.V. (IFRX) Reports Q2 Loss, Misses Revenue Estimates - MSN
Will breakout in InflaRx N.V. lead to full recoveryJuly 2025 Intraday Action & Free Weekly Watchlist of Top Performers - Newser
Will InflaRx N.V. see short term momentumPortfolio Gains Report & Daily Risk Controlled Trade Plans - Newser
InflaRx N.V. stock momentum explainedBuy Signal & Safe Capital Growth Plans - Newser
Building trade automation scripts for InflaRx N.V.Weekly Trade Analysis & Risk Controlled Daily Trade Plans - Newser
Published on: 2025-08-24 11:00:06 - Newser
What’s the fair value of InflaRx N.V. stockJuly 2025 Momentum & Risk Managed Investment Signals - theviewers.co.kr
Combining machine learning predictions for InflaRx N.V.Portfolio Value Report & Stepwise Swing Trade Plans - Newser
Why is InflaRx N.V. stock going upQuarterly Portfolio Report & AI Enhanced Trading Alerts - sundaytimes.kr
Sell Signal: What are InflaRx N.V.’s technical support levelsWatch List & AI Powered Trade Plan Recommendations - sundaytimes.kr
Inflarx N.V. shares fall 1.34% intraday after announcing participation in September investor conferences. - AInvest
InflaRx to participate in Cantor Global Healthcare Conference, H.C. Wainwright 27th Annual Global Investment Conference. - AInvest
InflaRx Announces Participation in September Investor Conferences - GlobeNewswire
Biotech Innovator InflaRx to Showcase Anti-Inflammatory Pipeline at Major September Healthcare Conferences - Stock Titan
What to do if you’re stuck in InflaRx N.V.Portfolio Performance Summary & Weekly Watchlist of Top Performers - Newser
InflaRx N.V. Stock Approaches Key Moving AverageJuly 2025 Opening Moves & Verified Trade Idea Suggestions - 더경남뉴스
Real time social sentiment graph for InflaRx N.V.Analyst Upgrade & Growth Oriented Trading Recommendations - Newser
InflaRx N.V. stock chart pattern explained2025 Top Gainers & Stepwise Trade Signal Implementation - Newser
Regression analysis insights on InflaRx N.V. performanceJuly 2025 Volume & Free Community Supported Trade Ideas - Newser
What makes InflaRx N.V. stock price move sharply2025 Price Momentum & Risk Managed Trade Strategies - Newser
How moving averages guide InflaRx N.V. tradingOil Prices & Short-Term High Return Ideas - Newser
InflaRx receives Nasdaq notice for non-compliance with minimum bid price rule - MSN
Is InflaRx N.V. Stock a Good Fit for Conservative InvestorsQuarterly Profit Review & Long-Term Capital Growth Strategies - Newser
XTX Topco Ltd Buys New Shares in InflaRx N.V. (NASDAQ:IFRX) - Defense World
Finanzdaten der Inflarx N V-Aktie (IFRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):